Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

180 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survivin-targeted immunotherapy drives robust polyfunctional T cell generation and differentiation in advanced ovarian cancer patients.
Berinstein NL, Karkada M, Oza AM, Odunsi K, Villella JA, Nemunaitis JJ, Morse MA, Pejovic T, Bentley J, Buyse M, Nigam R, Weir GM, MacDonald LD, Quinton T, Rajagopalan R, Sharp K, Penwell A, Sammatur L, Burzykowski T, Stanford MM, Mansour M. Berinstein NL, et al. Among authors: nigam r. Oncoimmunology. 2015 May 7;4(8):e1026529. doi: 10.1080/2162402X.2015.1026529. eCollection 2015 Aug. Oncoimmunology. 2015. PMID: 26405584 Free PMC article.
First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients.
Berinstein NL, Karkada M, Morse MA, Nemunaitis JJ, Chatta G, Kaufman H, Odunsi K, Nigam R, Sammatur L, MacDonald LD, Weir GM, Stanford MM, Mansour M. Berinstein NL, et al. Among authors: nigam r. J Transl Med. 2012 Aug 3;10:156. doi: 10.1186/1479-5876-10-156. J Transl Med. 2012. PMID: 22862954 Free PMC article.
A study protocol for a feasibility randomised controlled trial investigating videoendoscopic radical inguinal lymphadenectomy versus open radical inguinal lymphadenectomy in patients with penile cancer (VELRAD).
Tang S, Akers C, Alnajjar H, Ayres B, Baldini C, Embleton-Thirsk A, Gurusamy K, Hadway P, Kumar V, Lau M, Nigam R, Pang K, Parnham A, Pizzo E, Ranieri V, Rees R, Sangar V, Wadke A, Williams N, Muneer A. Tang S, et al. Among authors: nigam r. Pilot Feasibility Stud. 2024 Apr 10;10(1):61. doi: 10.1186/s40814-024-01474-8. Pilot Feasibility Stud. 2024. PMID: 38600541 Free PMC article.
Long-term outcomes of penile squamous cell carcinoma in men age ≤50 years old compared with men >50 years old from a single tertiary referral centre: a propensity score matched analysis.
Pang KH, Fallara G, Hemat M, Ghosh A, Haider A, Freeman A, Hadway P, Nigam R, Rees R, Mitra A, Alifrangis C, Muneer A, Alnajjar HM. Pang KH, et al. Among authors: nigam r. Int J Impot Res. 2024 Feb 29. doi: 10.1038/s41443-024-00842-5. Online ahead of print. Int J Impot Res. 2024. PMID: 38424353
The World Federation of Hemophilia World Bleeding Disorders Registry: insights from the first 10,000 patients.
Coffin D, Gouider E, Konkle B, Hermans C, Lambert C, Diop S, Ayoub E, Tootoonchian E, Youttananukorn T, Dakik P, Pereira T, Iorio A, Pierce GF; World Bleeding Disorders Registry Participating Investigators. Coffin D, et al. Res Pract Thromb Haemost. 2023 Nov 20;7(8):102264. doi: 10.1016/j.rpth.2023.102264. eCollection 2023 Nov. Res Pract Thromb Haemost. 2023. PMID: 38193052 Free PMC article.
Primary squamous cell carcinoma of the scrotum: Outcomes from a specialist center.
Pang KH, Fallara G, Tang S, Haider A, Freeman A, Hadway P, Nigam R, Rees R, Mitra A, Alifrangis C, Bunker C, Alnajjar HM, Muneer A. Pang KH, et al. Among authors: nigam r. Urol Oncol. 2023 Dec;41(12):488.e11-488.e18. doi: 10.1016/j.urolonc.2023.08.006. Epub 2023 Oct 29. Urol Oncol. 2023. PMID: 37903660
Focal therapy versus radical prostatectomy and external beam radiotherapy as primary treatment options for non-metastatic prostate cancer: results of a cost-effectiveness analysis.
Reddy D, van Son M, Peters M, Bertoncelli Tanaka M, Dudderidge T, Cullen E, Ho CLT, Hindley RG, Emara A, McCracken S, Orczyk C, Shergill I, Mangar S, Nigam R, Virdi J, Moore CM, Arya M, Shah TT, Winkler M, Emberton M, Falconer A, Belsey J, Ahmed HU. Reddy D, et al. Among authors: nigam r. J Med Econ. 2023 Jan-Dec;26(1):1099-1107. doi: 10.1080/13696998.2023.2251849. J Med Econ. 2023. PMID: 37656223 Free article.
180 results